Cryptome CEO resigns

By Melissa Trudinger
Tuesday, 19 October, 2004

Cryptome Pharmaceuticals (ASX: CRP) has announced that CEO Jeffrey Travis has resigned for personal reasons.

US expatriate Travis, who was appointed in January shortly after the company floated on the ASX, is expected to return to the US. The company plans to appoint an interim CEO in the near future.

Hormone therapy shifts body proteins to match gender identity

Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...

Targeting 'molecular bodyguards' weakens prostate cancer cells

Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...

Females found to carry a higher genetic risk of depression

An international team of scientists has discovered about twice as many genetic 'flags'...

Content from other channels on our network

Discovery improves silicon solar efficiency

Partnership to redefine thermal comfort index

Dashboard to support climate-aware business decisions

Australia's homes aren’t ready for the heat — here's how to fix them

Program assists power station workers to find new careers

Roma Foods celebrates over 70 years of Australian manufacturing

Rock lobster exporter improves supply chain efficiency

Butter maker required sanitary measurement solution

CCEP's reverse vending machine rollout

Bottle-filling physics: keeping it calm to prevent sloshing

Keeping Infection Prevention Front of Mind – Every Day of the Year

WA invests $1.5bn in three major new public hospital projects

Framework seeks to cut medicine errors at transitions of care

Nominations open for 2026 HESTA Australian Nursing & Midwifery Awards

Report explores Australian perceptions of Medtech access